Vallone Carol A 4
4 · Definium Therapeutics, Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
Definium (DFTX) Director Carol Vallone Receives RSU Award
What Happened
Carol A. Vallone, a director of Definium Therapeutics (DFTX), received equity awards on 2026-06-11 consisting of two acquisitions: 4,666 shares (award) and 19,188 derivative shares (RSUs), for a total of 23,854 RSUs. Each was granted at $0.00 (no cash paid). These are compensation awards (not open-market purchases or sales).
Key Details
- Transaction date: 2026-06-11; reported on Form 4 filed 2026-06-15 (filed timely).
- Grant amounts and price: 4,666 shares @ $0.00 (acquired); 19,188 derivative RSUs @ $0.00 (acquired). Total = 23,854 RSU-equivalents.
- Shares owned after transaction: not disclosed in the filing.
- Footnotes from the filing:
- F1: The 19,188 (and/or RSU-related awards) are restricted stock units (RSUs); each RSU converts to one common share when vested. RSUs vest 1/12th of the underlying shares each month, with a possible acceleration to vest immediately prior to the next annual meeting if that meeting occurs before the first anniversary, subject to continued service.
- F2: The filing also includes a standard vesting note for stock options (1/12th monthly vesting and similar acceleration clause); this report does not show an option exercise or sale by the director.
- No sale/exercise or cashless transaction reported — these are awards only.
Context
RSU grants are a common form of executive and director compensation and represent a future right to receive shares if vesting conditions are met; they are not immediate purchases or sales and don’t by themselves signal a director buying or selling stock. The awards vest over time (monthly) and are contingent on continued service (with a potential acceleration clause tied to the company’s annual meeting).
Insider Transaction Report
- Award
Common Shares
[F1]2026-06-11+4,666→ 21,210 total - Award
Stock Option (Right to Buy)
[F2]2026-06-11+19,188→ 19,188 totalExercise: $24.11Exp: 2036-06-10→ Common Shares (19,188 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
- [F2]The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.